|AFFILIATION:||Australian National University, Acton, ACT, Australia|
Track: Medical & Biotech
Tech Readiness: TRL 7
Tech Brief: Traumatic brain injury, depression and other factors increase the risk of Alzheimer’s Disease (AD). We have developed scientifically-validated tools targeted at middle aged adults and designed to measure, monitor, and reduce the risk of developing late life AD, promoting healthy aging and considerable savings on direct and indirect costs.
Value Proposition: While the incidence of AD is significant amongst the general population there is evidence to suggest that the number of at-risk veterans goes beyond the impact of population ageing as a result of the increasing incidence traumatic brain injury and posttraumatic stress disorder. It is a paradox of improvements in military health and battlefield survival that veterans will be a greater risk of developing chronic neurodegenerative diseases such as AD1. The associated costs in terms of health care costs and productivity are significant. Our studies have shown that assessment of risk factors and intervention in terms to reduction in modifiable risk factors in individuals at 55 will have a positive impact on outcomes for the individual – even those with traumatic brain injury. The tools do not require face to face contact and so can be rolled out easily and inexpensively across a geographically spread organization.
Org Type: Academic/Gov Lab